Check out this answer from Consensus:

SSRIs are effective in treating depressive disorders in teenagers, with fluoxetine showing the most consistent evidence of efficacy. However, their use is associated with an increased risk of suicidal ideation and behavior, necessitating careful monitoring and risk-benefit analysis. Further research is needed to fully understand the long-term impact of SSRIs on the developing adolescent brain and to optimize treatment strategies for this vulnerable population.

Selective serotonin reuptake inhibitors (SSRIs) are commonly prescribed antidepressants for treating depressive disorders in teenagers. However, their efficacy and safety in this age group have been subjects of ongoing debate. This article aims to review the current evidence on the effectiveness and potential risks associated with SSRI use in adolescents.

Efficacy of SSRIs in Teenagers

Several studies have investigated the efficacy of SSRIs in treating depressive disorders in teenagers. A meta-analysis of randomized controlled trials (RCTs) found that SSRIs are more effective than placebo in reducing depressive symptoms in children and adolescents, with a relative risk (RR) of 1.28 (95% CI 1.17 to 1.41)1. Fluoxetine, in particular, showed consistent evidence of effectiveness in reducing depression symptoms (CDRS-R treatment effect -5.63, 95% CI -7.38 to -3.88) and improving response rates (RR 1.86, 95% CI 1.49 to 2.32)1. Another systematic review and meta-analysis confirmed that SSRIs and serotonin-norepinephrine reuptake inhibitors (SNRIs) are more beneficial than placebo in treating depressive disorders in children and adolescents, although the effect size was small (g = 0.32; 95% CI, 0.25-0.40)2. The review also highlighted that SSRIs produced a relatively large effect size for anxiety disorders (g = 0.71; 95% CI, 0.45-0.97) compared to depressive disorders2.

Safety Concerns and Adverse Effects

Despite their efficacy, SSRIs are associated with several safety concerns, particularly the risk of increased suicidal ideation and behavior. A comprehensive review concluded that SSRIs carry a small risk of inducing suicidal thoughts and suicide attempts in individuals below 25 years of age, with the risk decreasing further at the age of about 30-40 years3. This risk has led to warnings from regulatory authorities such as the FDA and MHRA3. A study examining the adverse effects of antidepressants in children and adolescents found that those receiving SSRIs reported significantly more treatment-emergent adverse events (RR, 1.07; 95% CI, 1.01-1.12) and severe adverse events (RR, 1.76; 95% CI, 1.34-2.32) compared to those receiving placebo2. Another study noted that the tolerability of SSRIs might complicate treatment or lead to discontinuation7.

Impact on the Developing Brain

The impact of SSRIs on the developing adolescent brain remains unclear. While some studies suggest that SSRIs do not pose a significant developmental risk, others emphasize the need for careful medical judgment to ensure that the benefits outweigh the risks for individual patients6. A review highlighted the importance of understanding the mechanisms of action of SSRIs and their effects on the adolescent brain to better inform treatment decisions8.

Do SSRIs (antidepressants) work in teenagers?

Marc Stone has answered Likely An expert from Food and Drug Administration USA in Clinical Trials, Epidemiology

First of all, the term "antidepressant" is a little misleading. A large number of drugs have been shown to reduce symptoms of depression, at least in adults, but they work in a variety of ways. Many of them are also effective in conditions other than depression. It is better to classify drugs by their mechanism of action. The most commonly used class of "antidepressants" is the selective serotonin reuptake inhibitors (SSRIs). Ironically, there is clear evidence that SSRIs work in teenagers with generalized anxiety disorder (I would call it "near certain").

The evidence is murkier for depression. A number of randomized controlled trials treating teenagers with major depressive disorder have shown greater improvement with SSRIs (particularly fluoxetine (Prozac) than with placebo but many studies have had negative results. A "negative" result often doesn't mean there was no effect, only that the difference between drug and placebo was so small that chance variation cannot be excluded. So what happened? Mostly, these studies failed to take into account the possibility of a large placebo effect. Not only can suggestion (placebo effect) have a large impact on mood but many patients with depression experience large variability in their symptoms over time from very depressed to mildly depressed and back again. Most studies recruit patients with moderate to severe depression because there is so little potential for improvement if depression is mild. However, many of these patients with more severe depression are just experiencing a worsened fluctuation in their condition that will improve spontaneously. Fluctuations and placebo effects tend to be larger in teenagers. Depression is harder to diagnose in teenagers, there is less history to go on and teenagers are less able to articulate their feelings, so studies in teenagers tend to include more patients that are misdiagnosed as having depression. Teenagers may also be less cooperative about taking their medications and showing up for assessments at study visits.

Finally, the law that encourages drug companies to do studies in teenagers contains a perverse incentive: companies receive a benefit, a longer period of exclusive marketing for their drug, if they complete studies in children (including teenagers) whether or not those studies show the drug to work in these patients. This encourages speed over quality. Because it is more difficult to recruit patients within a small age range, investigators may loosen their standards for acceptance of patients into the study. This allows the study to be completed more quickly but makes it less likely the study will show positive results even if the drug works.

Do SSRIs (antidepressants) work in teenagers?

John Read has answered Extremely Unlikely An expert from University of East London in Psychology

There has been little testing of SSRIs on teenagers. Since there is little evidence that SSRIs are better than placebo for adults (see reviews uy Irving Kirsch and others) , there is no reason to assume they would work for teenagers. In addition they have a range of severe adverse effects, including increased suicidality (especially common in younger people) which cannot be described as helpful.

READ, J., CARTWRIGHT, C., GIBSON, K. (2014). Adverse emotional and interpersonal effects reported by 1,829 New Zealanders while taking antidepressants. Psychiatry Research 216, 67-73.

Some individual teenagers may feel better, short-term, largely because of placebo (hope and expectation) but they will be exposed to risk of all the adverse effects, and the drugs wont address whatever is causing the teenager to feel depressed.

Do SSRIs (antidepressants) work in teenagers?

Peng Xie has answered Uncertain An expert from Chongqing Medical University in Psychiatry, Neurology

This is a complex question. We should have a comprehensive consideration.

According to the recent data from RCTs and meta-analysis, SSRIs, espectially for fluoxetine, may be efficacious for the treatment of teenagers with MDD. However, the most concerns should be drawn for the use of these drugs in adolescents is the potential increased suicide risk. The mechanism for this remain unknown. Therefore, whether or not to prescribe SSRIs for teenagers depends on many individual factors, such as severity of disease, accessibility for psychotherapies, medication compliance, family and cultural background, and the acceptability of suicide risk or any other side effects for family members.

Do SSRIs (antidepressants) work in teenagers?

Helen Keeley has answered Likely An expert from Irish Health Service Executive in Psychiatry

Meta-analysis shows that some SSRI's are effective for young people with moderate to severe depression but this must be balanced against an increased risk of side effects including suicidality, especially in the early phase of treatment. Many antidepressants used in adults are not suitable for use in teenagers for this reason so care must be taken in this regard.

Do SSRIs (antidepressants) work in teenagers?

Ian M Goodyer has answered Likely An expert from University of Cambridge in Psychopathology, Psychiatry

Antidepressants do have therapeutic effects in depressed adolescents

Considering good methodological trials of depressed adolescents with a rigorous level of measures and monitoring gives efficacy rates some 20-25% greater than placebo. The strongest current evidence for efficacy is for fluoxetine which gave a standardised mean difference = 0.51, a moderate to good effect indicating that 69% off those patients were below the mean depression score of the control group. This compares quite favourably to results obtained in depressed adolescents given CBT alone where an average standardised mean difference = 0.31 form a number of published studies.

UK NICE prescribing guidelines recommend fluoxetine with a psychological treatment for moderate to severe depressed adolescents. For mild cases fluoxetine should not be prescribed and a psychological treatment be tried in the first instance. Finally, clinical benefits from fluoxetine need to be weighed against their documented side-effects, both physical and psychological.

Of importance, is the observation that suicidal thoughts are more common in depressed adolescents prescribed an SSRI than those prescribed placebos. The pattern of suicide attempts before and after starting medication have however been noted as equivalent in those starting fluoxetine medication. Helpfully, there is no evidence to date that antidepressants are associated with any negative effects on the developing adolescent brain, so clinicians do not have to take neural risks into account when weighing the benefits against the risk of prescribing fluoxetine. We have yet to have any systematic studies of side effects from psychological treatments of depressed adolescents. Treatment drop out of depressed adolescents from psychotherapies is likely to contain some patients with therapy induced side effects. This is a source of considerable research at this time and is long overdue. Overall the key question ‘what treatment works best for which depressed patient’ remains unanswered. SSRI medication, especially fluoxetine, is part of the solution for some such patients.